Melanoma In Situ-Getting the Diagnosis and Prognosis Right
JAMA Dermatol
.
2023 Jul 1;159(7):699-701.
doi: 10.1001/jamadermatol.2023.1485.
Authors
Anne E Cust
1
2
3
,
Richard A Scolyer
2
4
5
6
Affiliations
1
The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.
2
Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
3
Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
4
Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
5
Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.
6
Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
PMID:
37285137
DOI:
10.1001/jamadermatol.2023.1485
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Melanoma* / diagnosis
Prognosis
Skin Neoplasms* / diagnosis
Supplementary concepts
Melanoma, Cutaneous Malignant